Dr. Mardi R. Karin, MD

Dr. Karin practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Karin's NPI, 1275568388, was assigned on July 11, 2006. Dr. Karin graduated from David Geffen School of Medicine at UCLA in 1985. Dr. Karin's California license number on file is G68578.

Dr. Karin's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Karin's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Karin is also affiliated with Good Samaritan Hospital. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Karin to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Karin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karin practices, 5 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Karin's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Karin is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Karin's licenses on file in 2 states: California and Illinois.

Dmand AI lists mastectomy among the conditions Dr. Karin treats.

CMS data shows 298 Medicare services from Dr. Karin across 7 procedure codes in 2024, for 118 Medicare patients. Medicare paid $55,801 for them. Every service was in an office.

CMS counts 118 Medicare patients who saw Dr. Karin in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have cancer, and 73% have high cholesterol. 11% are also on Medicaid. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Karin's median patient age at 57, with 97% women.

In 2024, Dr. Karin wrote 23 Medicare Part D claims for 20 patients. 100% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $21 in total drug cost. In 2023, CMS named 32 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Karin for performance year 2024, reported as part of a group. Dr. Karin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Karin as offering telehealth. CMS counts 64 procedures of mastectomy by Dr. Karin, more than 97% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Karin, published from 2019 to 2023. 2022 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Mastectomy and Necrosis. Dr. Karin's most frequent co-authors are Irene Leonor Wapnir, MD, Arash Momeni, MD and Arash Keshmiri Momeni, MD.

Dmand AI links Dr. Karin to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Breast Cancer Lymphedema and Lymphedema.

CMS Open Payments shows 27 general payments to Dr. Karin from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Cianna Medical Inc paid the most, $401.

Dr. Karin graduated from David Geffen School of Medicine at UCLA in 1985.

Dr. Karin is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.